Cargando…

TLR7 Activation Accelerates Cardiovascular Pathology in a Mouse Model of Lupus

We report a novel model of lupus-associated cardiovascular pathology accelerated by the TLR7 agonist R848 in lupus-prone B6.Sle1.Sle2.Sle3 (TC) mice. R848-treated TC mice but not non-autoimmune C57BL/6 (B6) controls developed microvascular inflammation and myocytolysis with intracellular vacuolizati...

Descripción completa

Detalles Bibliográficos
Autores principales:	Elshikha, Ahmed S., Teng, Xiang Yu, Kanda, Nathalie, Li, Wei, Choi, Seung-Chul, Abboud, Georges, Terrell, Morgan, Fredenburg, Kristianna, Morel, Laurence
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9289616/ https://www.ncbi.nlm.nih.gov/pubmed/35860280 http://dx.doi.org/10.3389/fimmu.2022.914468

Ejemplares similares

TLR7/TLR8 activation and susceptibility genes synergize to breach gut barrier in a mouse model of lupus
por: Ma, Longhuan, et al.
Publicado: (2023)

Pharmacologic inhibition of glycolysis prevents the development of lupus by altering the gut microbiome in mice
por: Elshikha, Ahmed S., et al.
Publicado: (2023)

D-mannose ameliorates autoimmune phenotypes in mouse models of lupus
por: Wang, Haiting, et al.
Publicado: (2021)

Lupus susceptibility gene Esrrg modulates regulatory T cells through mitochondrial metabolism
por: Li, Wei, et al.
Publicado: (2021)

Inhibition of Glycolysis Reduces Disease Severity in an Autoimmune Model of Rheumatoid Arthritis
por: Abboud, Georges, et al.
Publicado: (2018)

Alpha 1 Antitrypsin Gene Therapy Extends the Lifespan of Lupus-Prone Mice
por: Elshikha, Ahmed Samir, et al.
Publicado: (2018)

Transcriptional and metabolic programs promote the expansion of follicular helper T cells in lupus-prone mice
por: Gong, Minghao, et al.
Publicado: (2023)

Our Journey from the Study of Human Autoantibodies to the microRNA World
por: Fredenburg, Kristianna M., et al.
Publicado: (2015)

Microbiota-mediated skewing of tryptophan catabolism modulates CD4(+) T cells in lupus-prone mice
por: Brown, Josephine, et al.
Publicado: (2022)

Targeting T Cell Activation and Lupus Autoimmune Phenotypes by Inhibiting Glucose Transporters
por: Li, Wei, et al.
Publicado: (2019)

Cervical cancer with a rare umbilical metastases in prior surgical site
por: Kharod, Shivam, et al.
Publicado: (2015)

Smoking-related diffuse cystic lung disease
por: Ataya, Ali, et al.
Publicado: (2019)

Alpha 1 Antitrypsin Inhibits Dendritic Cell Activation and Attenuates Nephritis in a Mouse Model of Lupus
por: Elshikha, Ahmed S., et al.
Publicado: (2016)

Protective Role of Myeloid Cells Expressing a G-CSF Receptor Polymorphism in an Induced Model of Lupus
por: Sivakumar, Ramya, et al.
Publicado: (2018)

Iron Metabolism: An Under Investigated Driver of Renal Pathology in Lupus Nephritis
por: Wlazlo, Ewa, et al.
Publicado: (2021)

Alpha-1-Antitrypsin Ameliorates Pristane Induced Diffuse Alveolar Hemorrhage in Mice
por: Elshikha, Ahmed S., et al.
Publicado: (2019)

Loss of RE-1 silencing transcription factor accelerates exocrine damage from pancreatic injury
por: Bray, Julie K., et al.
Publicado: (2020)

Vascular Inflammation in Mouse Models of Systemic Lupus Erythematosus
por: Ryan, Holly, et al.
Publicado: (2022)

Characterization of GATA3 and Mammaglobin in breast tumors from African American women
por: Ricks-Santi, Luisel J., et al.
Publicado: (2023)

Genetic Variations Controlling Regulatory T Cell Development and Activity in Mouse Models of Lupus-Like Autoimmunity
por: Roach, Tracoyia, et al.
Publicado: (2022)

Loss of Gut Barrier Integrity In Lupus
por: Ma, Longhuan, et al.
Publicado: (2022)

Severity of Influenza A(H1N1) Illness and Emergence of D225G Variant, 2013–14 Influenza Season, Florida, USA
por: Iovine, Nicole M., et al.
Publicado: (2015)

Lupus acceleration by a MAVS-activating RNA virus requires endosomal TLR signaling and host genetic predisposition
por: Gonzalez-Quintial, Rosana, et al.
Publicado: (2018)

TLR7 Agonism Accelerates Disease and Causes a Fatal Myeloproliferative Disorder in NZM 2410 Lupus Mice
por: Wirth, Jena R., et al.
Publicado: (2020)

The combination of two Sle2 lupus-susceptibility loci and Cdkn2c deficiency leads to T cell-mediated pathology in B6.Fas(lpr) mice
por: Xu, Zhiwei, et al.
Publicado: (2013)

Inhibition of glucose metabolism selectively targets autoreactive follicular helper T cells
por: Choi, Seung-Chul, et al.
Publicado: (2018)

A 40-Year-Old Woman With COVID-19 and Bilateral Vision Loss
por: Jain, Varun, et al.
Publicado: (2022)

Immune Response-Dependent Assembly of IMP Dehydrogenase Filaments
por: Calise, S. John, et al.
Publicado: (2018)

A Variant of the Histone-Binding Protein sNASP Contributes to Mouse Lupus
por: Ju, Jiyu, et al.
Publicado: (2019)

TLR-9, but not TLR-2, TLR-3 and TLR-4, is upregulated on peripheral blood mononuclear cells of patients with active systemic lupus erythematosus
por: Papadimitraki, ED, et al.
Publicado: (2005)

Association of TLR7 and TLR9 genes polymorphisms in Egyptian patients with systemic lupus erythematosus
por: Azab, Marwa M., et al.
Publicado: (2022)

The Role of the Oxidative State and Innate Immunity Mediated by TLR7 and TLR9 in Lupus Nephritis
por: Echavarria, Raquel, et al.
Publicado: (2023)

Murine Models of Systemic Lupus Erythematosus
por: Perry, Daniel, et al.
Publicado: (2011)

B cell–intrinsic TLR7 expression drives severe lupus in TLR9-deficient mice
por: Cosgrove, Haylee A., et al.
Publicado: (2023)

Development of a systemic lupus erythematosus cardiovascular risk equation
por: Petri, Michelle A, et al.
Publicado: (2019)

Immune metabolism regulation of the germinal center response
por: Choi, Seung-Chul, et al.
Publicado: (2020)

Roles of B Cell-Intrinsic TLR Signals in Systemic Lupus Erythematosus
por: Ma, Kongyang, et al.
Publicado: (2015)

TLR7 gain-of-function genetic variation causes human lupus
por: Brown, Grant J., et al.
Publicado: (2022)

TLR7-dependent and FcγR-independent production of type I interferon in experimental mouse lupus
por: Lee, Pui Y., et al.
Publicado: (2008)

Safety and efficacy of the SGLT2 inhibitor dapagliflozin in patients with systemic lupus erythematosus: a phase I/II trial
por: Wang, Huijing, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_gd03c1o2rin2ebe21tvc5hkqq9